This product should be used in pregnant women or women who may possibly be pregnant only if the expected therapeutic benefits outweigh the possible risks associated with treatment. [The safety of this product for use during pregnancy has not been established. An animal study (in rats) has reported that this product is transferred to the fetus.]
In lactating women, breast-feeding must be discontinued during treatment. [An animal study (in rats) has reported that this product is excreted in breast milk.]